"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q1
Compliance Under Regulation 23(9)Of SEBI Regualtion, 2015
Intimation Of Appointment Of As Chief Financial Officer
Intimation For Appointment Of Company Secretary
Outcome of Board Meeting
Outcome of Board Meeting
Intimation Of Non Applicability Of Annual Secretarial Compliance Report For The Year Ended 31-03-019
Board Meeting Intimation for Notice Of Board Meeting
Report On The Voting Conducting Through Ballot And E-Voting At The NCLT Convened Meeting Of The Equity Shareholders For The Pharmaids Pharmaceuticals Ltd.
Outcome Of The NCLT Convened Meeting
Regulation 30 - Proceedings Of The NCLT Convened Meeting Of The Equity Shareholders Reg., Held On May 11, 2019
Certificate Under Regulation 40(9) Of SEBI
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication intimation
Outcome of Board Meeting
Outcome of Board Meeting
Closure of Trading Window
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 5Th April,2019
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us